Regenerative Medical Technology (RMTG) Current Deferred Revenue (2021 - 2026)
Regenerative Medical Technology (RMTG) reported Current Deferred Revenue of $431,936 for Q2 2026, up 254.7% from $121,770 a year earlier but down 14.4% from the prior quarter.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) Current Deferred Revenue (2021 - 2026) Analysis & Trends
At the end of FY2025, Regenerative Medical Technology posted Current Deferred Revenue of $351,193, up 530.7% from FY2024.
- Current Deferred Revenue has a four-year compound annual growth rate of 109.5% (FY2021 to FY2025).
- By year, Current Deferred Revenue came in at $55,684 in FY2024, $2,000 in FY2023 (-80.9%), $10,450 in FY2022 (-42.6%) and $18,215 in FY2021.
- Five-year quarterly Current Deferred Revenue spans a low of $500.00 in Q2 2023 and a high of $504,892 in Q1 2026.
- Year over year, Current Deferred Revenue gained in three of the last five quarters, with growth averaging 153.0%.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2025 (growth of 530.7%); the low point was Q4 2023 (a decline of 80.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $504,892 (Q1 2026), $351,193 (Q4 2025) and $172,146 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Regenerative Medical Technology | 824,338.06 | -3.70 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 431,936.00 |
| Mar 31, 2026 | 504,892.00 |
| Dec 31, 2025 | 351,193.00 |
| Sep 30, 2025 | 172,146.00 |
| Jun 30, 2025 | 121,770.00 |
| Mar 31, 2025 | 35,816.00 |
| Dec 31, 2024 | 55,684.00 |
| Sep 30, 2024 | 79,850.00 |
| Jun 30, 2024 | 372,860.00 |
| Mar 31, 2024 | 114,880.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 1,500.00 |
| Jun 30, 2023 | 500.00 |
| Mar 31, 2023 | 20,508.00 |
| Dec 31, 2022 | 10,450.00 |
| Dec 31, 2021 | 18,215.00 |
API Access
Regenerative Medical Technology Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();